aTyr Pharma Inc reports results for the quarter ended in March - Earnings Summary

aTyr Pharma

09/05/2022 22:03

* aTyr Pharma Inc  LIFE.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 33
cents per share.
    * Reported revenue was zero​;  analysts expected $166.67
thousand. 
    * aTyr Pharma Inc's reported EPS for the quarter was a loss
of 44
cents​.
    * The mean earnings estimate of analysts had risen by
about 25.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * aTyr Pharma Inc shares had fallen by 27.0% this
quarter and
lost 47.7% so far this year.
    * The company reported a quarterly loss of $12.15 million.
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 09:03 p.m.  ​All
figures in US dollars unless otherwise stated